PMID- 7977782 OWN - NLM STAT- MEDLINE DCOM- 19941208 LR - 20171213 IS - 0002-9513 (Print) IS - 0002-9513 (Linking) VI - 267 IP - 5 Pt 2 DP - 1994 Nov TI - Coordinate regulation of 11 beta-HSD and Ke 6 genes in cpk mouse: implications for steroid metabolic defect in PKD. PG - F791-7 AB - Polycystic kidney disease (PKD) is characterized by multiple renal cysts, which ultimately result in renal failure. We have reported the identification of a new gene, Ke 6, within the major histocompatibility complex, which is downregulated in two different mouse models of heritable PKD (N. Aziz, M. Maxwell, B. St.-Jacques, and B.M. Brenner. Mol. Cell. Biol. 13: 1847-1853, 1993). The Ke 6 gene gives rise to two transcripts, Ke 6a and Ke 6b. Ke 6a protein has significant homology to several mammalian and bacterial steroid dehydrogenases. The homology of Ke 6a protein to specific functional domains of the human and rat 11 beta-hydroxysteroid dehydrogenase enzyme (11 beta-HSD), which inactivates glucocorticoids, is substantial. We report here that the Ke 6 gene and the 11 beta-HSD gene are regulated in the same aberrant pattern in the cpk mouse. The strong evidence for a critical role of steroids in cystogenesis leads us to propose that a possible elevation of intrahepatic and intrarenal steroid levels occurs in the cpk mouse as a result of repression of steroid metabolic enzymes, which ultimately leads to development of cysts. FAU - Aziz, N AU - Aziz N AD - Department of Medicine, Children's Hospital, Boston, Massachusetts. FAU - Maxwell, M M AU - Maxwell MM FAU - Brenner, B M AU - Brenner BM LA - eng GR - DK-35930/DK/NIDDK NIH HHS/United States GR - DK-48098/DK/NIDDK NIH HHS/United States PT - Comparative Study PT - Journal Article PT - Research Support, U.S. Gov't, P.H.S. PL - United States TA - Am J Physiol JT - The American journal of physiology JID - 0370511 RN - 0 (Glucocorticoids) RN - 0 (H2-Ke6 protein, mouse) RN - 0 (Histocompatibility Antigens) RN - 0 (RNA, Messenger) RN - 0 (Steroids) RN - EC 1.- (Oxidoreductases) RN - EC 1.1.- (Hydroxysteroid Dehydrogenases) RN - EC 1.1.1.- (Hydroxyprostaglandin Dehydrogenases) RN - EC 1.1.1.141 (15-hydroxyprostaglandin dehydrogenase) RN - EC 1.1.1.146 (11-beta-Hydroxysteroid Dehydrogenases) SB - IM GS - Ke 6 MH - 11-beta-Hydroxysteroid Dehydrogenases MH - Amino Acid Sequence MH - Animals MH - Base Sequence MH - Blotting, Northern MH - Consensus Sequence MH - Conserved Sequence MH - *Gene Expression Regulation MH - Gene Expression Regulation, Enzymologic MH - Genetic Carrier Screening MH - Glucocorticoids/metabolism MH - Histocompatibility Antigens/*biosynthesis/genetics MH - Humans MH - Hydroxyprostaglandin Dehydrogenases/biosynthesis/genetics MH - Hydroxysteroid Dehydrogenases/*biosynthesis/genetics MH - Kidney/enzymology/immunology MH - Liver/enzymology/immunology MH - *Major Histocompatibility Complex MH - Mammals MH - Mice MH - Mice, Inbred DBA MH - Mice, Mutant Strains MH - Molecular Sequence Data MH - *Oxidoreductases MH - Polycystic Kidney Diseases/*genetics/immunology/metabolism MH - RNA, Messenger/isolation & purification/metabolism MH - Rats MH - Regulatory Sequences, Nucleic Acid MH - Sequence Homology, Amino Acid MH - Steroids/*metabolism MH - Transcription, Genetic EDAT- 1994/11/01 00:00 MHDA- 1994/11/01 00:01 CRDT- 1994/11/01 00:00 PHST- 1994/11/01 00:00 [pubmed] PHST- 1994/11/01 00:01 [medline] PHST- 1994/11/01 00:00 [entrez] AID - 10.1152/ajprenal.1994.267.5.F791 [doi] PST - ppublish SO - Am J Physiol. 1994 Nov;267(5 Pt 2):F791-7. doi: 10.1152/ajprenal.1994.267.5.F791.